跳至主要内容
临床试验/ACTRN12619000174189
ACTRN12619000174189尚未招募未知

Exercise as medicine for heart failure: A novel intervention to improve outcomes

The University of western Australia0 个研究点目标入组 100 人开始时间: 2019年2月6日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • NYHA Class II-IIIb with systolic dysfunction (HFrEF, EF <40%).
  • Willing and able to sign written informed consent prior to trial entry
  • Suitable to participate in a 16-week exercise training program, as determined by the medical history and physical examination

排除标准

  • Current smoking or smoking in the past 12 months,
  • Renal impairment (stage 4 or 5 CKD),
  • Exercise-induced ischaemia at a low workload (<3 METS),
  • Hypertension (>165/95mmHg)
  • Diagnosed peripheral artery disease

研究者

相似试验